HB Biotech
PrivateLast Round
Accelerator
Jul 1, 2023
Total Funding Raised
$191,000
Company Overview
HB Biotech operates in Healthcare & Life Sciences and is based in Araraquara. Its latest recorded funding round was an Accelerator round in July 2023.
HB Biotech is a biotechnology company that specializes in the industrial-scale production of bacterial cellulose for applications in the medical, pharmaceutical, food, and cosmetic industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HB Biotech Comparables
Compare HB Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theras Group | 71% | |
| Sanofi | 69% | |
| Glyscend Therapeutics | 66% |
For institutional investors. Book with your work email.
HB Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 1, 2023 | ||||
| Grant | Aug 17, 2022 |
For institutional investors. Book with your work email.
HB Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Suzano Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 148% MoM.
- Apr 23, 2026
Monthly visitors grew 72% MoM.
For institutional investors. Book with your work email.
HB Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HB Biotech's valuation, stock price, and market status.
Is HB Biotech a public or private company?
HB Biotech is a private company.
What is the current stock price of HB Biotech?
HB Biotech is a private company, so its shares have no public market price. Caplight tracks HB Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HB Biotech worth (valuation)?
Valuation information for HB Biotech is not publicly available.
Can I buy HB Biotech stock?
HB Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HB Biotech's last funding round?
HB Biotech's most recent funding round was Accelerator on July 1, 2023.
Who are the main investors in HB Biotech?
Key investors in HB Biotech include Suzano Ventures.
Will HB Biotech IPO soon?
No public IPO plans have been announced for HB Biotech.
How can I track HB Biotech secondary market activity?
Caplight tracks bids, offers, and trades in HB Biotech's shares on secondary markets.